Non-Fermenters - Emerging Health Care Pathogens
暂无分享,去创建一个
M. Kaur | S. Gupte | M. Kaur | M. Bala | P. Aggarwal | Tanveer Kaur | Ashwini Manhas
[1] D. Stableforth,et al. The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis , 2000, Drugs.
[2] Zhi-dong Hu,et al. Detection of OXA‐type carbapenemases and integrons among carbapenem‐resistant Acinetobactor baumannii in a Teaching Hospital in China , 2011, Journal of basic microbiology.
[3] V. Raia,et al. Sphingobacterium respiratory tract infection in patients with cystic fibrosis , 2009, BMC Research Notes.
[4] A. Malini,et al. Nonfermenting Gram-Negative Bacilli Infections in a Tertiary Care Hospital in Kolar, Karnataka , 2009, Journal of laboratory physicians.
[5] M. Vaneechoutte,et al. Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. , 2009, Journal of medical microbiology.
[6] C. Gerba,et al. Risk assessment of Pseudomonas aeruginosa in water. , 2009, Reviews of environmental contamination and toxicology.
[7] C. Stratton,et al. Acinetobacter septicus sp. nov. Association with a Nosocomial Outbreak of Bacteremia in a Neonatal Intensive Care Unit , 2008, Journal of Clinical Microbiology.
[8] Jong Moon Park,et al. A Case of Postoperative Sphingomonas paucimobilis Endophthalmitis After Cataract Extraction , 2008, Korean journal of ophthalmology : KJO.
[9] M. Willcox,et al. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. , 2007, Optometry and vision science : official publication of the American Academy of Optometry.
[10] E. Dellinger,et al. Necrotizing soft-tissue infection: diagnosis and management. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Luigi Chiarini,et al. Burkholderia cepacia complex species: health hazards and biotechnological potential. , 2006, Trends in microbiology.
[12] I. Vickers,et al. The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulation. , 2006, The West Indian medical journal.
[13] P. Fournier,et al. The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Bartlett,et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] N. Borrell,et al. Sphingobacterium multivorum isolated from a patient with cystic fibrosis , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[16] F. Huang,et al. Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[17] M. Martinez,et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces , 2003, Cellular microbiology.
[18] L. Calza,et al. Stenotrophomonas (Xanthomonas) maltophilia as an Emerging Opportunistic Pathogen in Association with HIV Infection: A 10-Year Surveillance Study , 2003, Infection.
[19] M. Marinella. Cellulitis and sepsis due to sphingobacterium. , 2002, JAMA.
[20] D. Georgieva,et al. The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia: characterization of the protein and molecular cloning of the gene. , 2002, The Journal of biological chemistry.
[21] M. Salkinoja-Salonen,et al. Characterization of Sphingomonas isolates from Finnish and Swedish drinking water distribution systems , 2000, Journal of applied microbiology.
[22] D. Landman,et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. L. Moreira,et al. Frequency of Nonfermentative Gram-Negative Bacilli Isolated from Clinical Materials of Pacients at Universidade Federal do Ceará Hospital Complex - Brazil , 1998 .
[24] J. Heritage,et al. Exceptional desiccation tolerance of Acinetobacter radioresistens. , 1998, The Journal of hospital infection.
[25] C. Goodwin,et al. Burn Wound Infections: Current Status , 1998, World Journal of Surgery.
[26] A. Prince,et al. Role of Flagella in Pathogenesis ofPseudomonas aeruginosa Pulmonary Infection , 1998, Infection and Immunity.
[27] C. Bizet,et al. Strains of Alcaligenes faecalis from clinical material. , 1997, The Journal of infection.
[28] K. Carroll,et al. Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. , 1996, The Journal of infectious diseases.
[29] F. Tekaia,et al. In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven beta-lactams. , 1993, The Journal of antimicrobial chemotherapy.
[30] K. Nikaido,et al. Identification and characterization of porins in Pseudomonas aeruginosa. , 1991, The Journal of biological chemistry.
[31] J. Freney,et al. Septicemia caused by Sphingobacterium multivorum , 1987, Journal of clinical microbiology.
[32] P. Liu,et al. Extracellular toxins of Pseudomonas aeruginosa. , 1974, The Journal of infectious diseases.